#Canada #Vancouver #mental health #Stella #Numinus Wellness

Numinus Wellness Enhances Access to Mental Health Care

In a significant development in the mental health sector, Numinus Wellness Inc. has officially transitioned its five wellness clinics in Utah to Stella, marking a strategic move to enhance the accessibility and management of mental health services. The sale, concluded for approximately $3.53 million, signals a new direction for Numinus as it refocuses its efforts on advancing its network and resources for mental health care providers.

A New Partnership to Strengthen Mental Health Services

Stella, a prominent player in interventional psychiatry dedicated to treating conditions like PTSD, anxiety, and depression, plans to maintain the high standards of care that Numinus clinics are known for. Michael Gershenzon, Co-Founder and CEO of Stella, emphasized that the alignment in care standards will allow both entities to collaboratively improve clinical mental health care across the nation. This partnership will enable operational data sharing between Stella and Numinus, thereby creating a tech-driven clinic management solution specifically designed for mental health practices.

A Strategic Shift for Numinus

With this transaction, Numinus is not only streamlining its operations but also innovating its approach to clinic management. The company aims to leverage its substantial experience in patient care as well as its relationships with insurers. Payton Nyquvest, founder and CEO of Numinus, expressed optimism about the potential of operational data to assist healthcare providers in better meeting the increasing treatment demands of patients.

As part of this strategy, Numinus is developing an AI-based Software as a Service (SaaS) solution that promises to redefine clinic operations—improving patient outcomes, enhancing efficiency, and optimizing reimbursement processes. With an estimated target market of over 200,000 mental health care providers in the U.S., this solution could revolutionize many practices.

Expanding Educational Resources and Research Capacity

In addition to the sale of clinics, Numinus continues to expand its educational and research offerings. The company’s Cedar Clinical Research division has become a key partner for major companies involved in drug development, including those focusing on psychedelic therapies. This year alone, Cedar Clinical has conducted 24 trials involving nearly 1,100 participants, reflecting a strong demand for research-backed mental health methodologies.

Furthermore, Numinus's practitioner training program is gaining momentum, attracting nearly 2,000 learners globally. This program, recognized by major regulatory bodies, aims to equip mental health professionals with the skills needed to incorporate innovative treatment approaches, including psychedelic-assisted therapies, into their practices.

Conclusion

The recent developments at Numinus Wellness represent a remarkable stride toward enhancing mental health access and management. By selling its clinics to Stella and focusing on innovative solutions, Numinus positions itself not only as a provider of mental health care but also as a vital resource for practitioners in the field. This pivotal shift will undoubtedly influence how mental health services are delivered and managed, paving the way for a more accessible and effective approach to mental health care in the U.S.

For further details, visit Numinus Wellness and Stella.